| Literature DB >> 35681900 |
Silvia Fernández-Martín1, Victoria Valiño-Cultelli2, Antonio González-Cantalapiedra1,2.
Abstract
The aim of this study was to examine the cardiorespiratory and blood changes associated with pneumoperitoneum (PNP) in laparoscopic ovariectomy (LAP Ove), as well as sevoflurane requirements, comparing them to those determined in open surgery (LPT Ove). The study was performed in 16 bitches submitted to LAP or LPT Ove. The cardiorespiratory and end-tidal sevoflurane concentration values were recorded as follows: at the beginning of surgery (T1), after the right ovary resection (T2), after the left ovary resection (T3), and after surgical closure (T4). Blood samples were taken before and after PNP. Among the cardiorespiratory parameters, no differences were observed in the values of end-tidal CO2, minute volume, and heart rate. In the LAP Ove group, a significant increase in inspiratory pressures and a decreased compliance were identified at T2 and T3. Significant higher arterial pressure values were observed in both groups at T2 and T3, with this increase especially marked at T2 in the LPT Ove group. Sevoflurane requirements were significantly higher in the LPT group during ovarian resection. Finally, in terms of the hematochemical parameters, statistical differences were recorded between pre- and post-operative assessments, but not between both surgical groups. The pathophysiological effects associated with PNP seemed to be transient and well-tolerated by healthy dogs.Entities:
Keywords: dog; intra-abdominal pressure; laparoscopy; laparotomy; mechanical ventilation; neutering; ovariectomy; pneumoperitoneum; sevoflurane
Year: 2022 PMID: 35681900 PMCID: PMC9179476 DOI: 10.3390/ani12111438
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Figure 1(a) Peak inspiratory pressure (Ppeak) and (b) Plateau pressure (Pplat) values determined at different points in time along the experimental period. Values given as a mean ± SD. p < 0.05: * vs. the LAP Ove group at the same time; a vs. T1 and b vs. T4 within the same Ove group.
Figure 2Compliance (C) values at different points in time along the experimental period. Values given as a mean ± SD. p < 0.05: * vs. the LAP Ove group at the same time; + vs. T1 within the same Ove group.
Figure 3Percentage of end-tidal sevoflurane concentration (FE’Sevo) at different points in time along the experimental period. Values given as a mean ± SD. p < 0.05: * vs. the LAP Ove group at the same time; + vs. T1 within the same Ove group.
Figure 4Invasive arterial blood pressure at different points in time along the experimental period. Values given as a mean ± SD. p < 0.05: * vs. the LAP Ove group at the same time; a vs. T1 and b vs. T4, within the same Ove group.
Pre- and postoperative arterial blood analysis.
| LAP Ove Group | LPT Ove Group | |||
|---|---|---|---|---|
| Variables | PRE | POST | PRE | POST |
| pH | 7.38 ± 0.05 | 7.39 ± 0.05 | 7.40 ± 0.04 | 7.41 ± 0.04 |
| PaCO2 (mmHg) | 41.25 ± 3 | 40.12 ± 4.3 | 41.9 ± 2.35 | 39.12 ± 4 |
| HCO3 (mEq/L) | 24.28 ± 1.7 | 23.1 ± 1.29 | 25.4 ± 1.34 | 24.75 ± 1.24 |
| BE (mmol/L) | −0.38 ± 1.8 | −1.6 ± 1.4 | 1.07 ± 1.44 | 0.46 ± 1.3 |
| PaO2 (mmHg) | 418 ± 58 | 434 ± 32 | 434 ± 40 | 429 ± 45 |
| Na++ (mmol/L) | 154.25 ± 2.8 |
| 150.5 ± 1.8 | |
| K+ (mmol/L) | 3.62 ± 0.4 | 3.99 ± 0.6 | 3.71 ± 0.2 |
|
| Cl− (mmol/L) | 119.25 ± 1.99 | 119 ± 1.5 | 117.62 ± 1.5 | 118 ± 1 |
Arterial blood data. Values given as a mean ± SD. Statistically significant differences are marked in “bold text”. p < 0.05: * vs. the LAP Ove group at the same time; + vs. pre-operative values within the same group.
Pre- and postoperative biochemical and hematologic analysis.
| LAP Ove Group | LPT Ove Group | |||
|---|---|---|---|---|
| Variables | PRE | POST | PRE | POST |
| GLU (mg/dL) | 102.9 ± 18.5 |
| 107.87 ± 17.2 |
|
| CREA (mg/dL) | 0.85 ± 0.14 | 0.85 ± 0.14 | 0.7 ± 0.15 | 0.71 ± 0.13 |
| TPP (g/dL) | 6.7 ± 0.6 |
| 6.5 ± 0.4 |
|
| ALB (g/dL) | 3.2 ± 0.16 |
| 2.9 ± 0.2 |
|
| GLOB (g/dL) | 3.57 ± 0.6 |
| 3.59 ± 0.35 |
|
| ALT (UI/L) | 39.37 ± 18.4 | 37.37 ± 22.2 | 34.6 ± 12.4 | 30.87 ± 13.5 |
| ALP (UI/L) | 49.87 ± 21.16 | 44.75 ± 20.1 | 45 ± 23.5 | 37 ± 19.6 |
| PCV (%) | 43.3 ± 7.3 |
| 43.3 ± 3.9 |
|
| HB (g/dL) | 15.82 ± 2.6 |
| 15.9 ± 1.16 |
|
| WBC (K/μL) | 11.34 ± 3.2 |
| 13.9 ± 2.38 | |
| PLT (K/μL) | 327.5 ± 127 |
| 324.5 ± 29.7 |
|
Venous blood data. Values given as mean ± SD. Statistically significant differences are marked in “bold text”. p < 0.05: * vs. the LAP Ove group at the same time; + vs. pre-operative values within the same group.